Hypertension (high blood pressure) decisions — 2025

The Board denied service connection for hypertension, finding that the evidence did not support a direct link between the Veteran's current condition and his military service.

The character of the appellant's discharge from active military service is not a bar to the receipt of Department of Veterans Affairs (VA) benefits, and service connection was granted for bilateral pes planus and bilateral tinnitus. However, service connection was denied for acquired psychiatric disorder, traumatic brain injury (TBI), heel spurs condition, right knee, left knee, lower lumbar back, hypertension, hemorrhoids, and sleep apnea.

The Board denied a compensable rating for hypertension and remanded the claim for service connection for atrial fibrillation.

The Board denied the veteran's claims for increased ratings and service connection, as well as dismissed his appeals due to untimeliness of his VA Form 10182.

The Board remands the claims for service connection for stroke, hypertension, diabetes mellitus, type II, and heart disease as secondary to service-connected disabilities due to duty-to-assist errors.

The appeal for service connection and rating claims was dismissed due to the failure to file a notice of disagreement within one year of the final rating decisions.

The Board remands the claims for service connection for a heart condition, arteriosclerosis, and hypertension to obtain additional medical opinions.

The Board denied service connection for bilateral hearing loss and hemorrhoids, while remanding claims for a low back disability, left knee disability, tension headaches, GERD, chronic constipation, and hypertension.

The Board denied service connection for bilateral hearing loss and an initial compensable rating for hypertension, but granted service connection for tinnitus. The claims for earlier effective date and peripheral neuropathy were remanded.

The Board remands the claims for service connection for a left shoulder condition, right shoulder condition, hypertension, and costochondritis for VA examinations to determine their etiology.

The Board denied service connection for bilateral hearing loss, an effective date prior to March 30, 2018, for the award of service connection for tinnitus, and a rating in excess of 10 percent for tinnitus. The Board also denied a compensable rating prior September 13, 2023, and a rating in excess of 10 percent on and after September 13, 2023, for maxillary sinusitis.

The Board remands the claims for service connection for an acquired psychiatric disability and hypertension as further development is needed to provide adequate medical examinations.

The Board remands the claims for further development, including verification of exposure to herbicide agents in Guam and obtaining a new medical opinion regarding skin disabilities.

The Board remands the claims for service connection for sleep apnea, a respiratory disorder (to include sinusitis), hypertension, gastroesophageal reflux disease (GERD), and alopecia as additional development is required before adjudication on the merits.

The Veteran was granted a 40 percent disability rating for hypertension from August 1, 2019 to September 18, 2019; however, a rating in excess of 10 percent at any other point during the appeal period is denied.

The appeal regarding entitlement to service connection for hypertension and a heart condition is remanded due to inadequate medical opinions.

The Veteran's service connection for hypertension is granted, while the claims for obstructive sleep apnea and a blood disorder are remanded.

The Board remands the matter for a new VA examination and medical opinion to determine the nature and etiology of any diagnosed heart conditions, including hypertension and cardiomyopathy.

The Board dismissed the appeal for service connection for blindness in right eye and granted readjudication of claims for sleep apnea, diabetes mellitus, type II, hypertension, and thyroid cancer based on new evidence.

The Board granted an initial 10 percent disability rating for hypertension effective from January 30, 2023. The service connection claims for erectile dysfunction and a disorder manifested by dizziness as secondary to hypertension were remanded.